Sylvamo Quarterly Results Meet Guidance

Financial Highlights – Second Quarter vs. First Quarter
*Net income from continuing operations of $49 million ($1.14 per diluted share) vs. $97 million ($2.25 per diluted share)
*Adjusted operating earnings1 (non-GAAP) of $49 million ($1.14 per diluted share) vs. $108 million ($2.51 per diluted share)
*Adjusted EBITDA2 (non-GAAP) of $124 million (13.5% margin) vs. $208 million (22.1% margin)
*Cash provided by operating activities from continuing operations of $77 million vs. $63 million
*Free cash flow3 (non-GAAP) of $33 million vs. $2 million

Summary from Chairman and Chief Executive Officer Jean-Michel Ribiéras:
We achieved our second quarter earnings per share and adjusted EBITDA objectives. We delivered these results while facing challenging market conditions and during our heaviest planned maintenance outage quarter.

Our sales volumes were similar to the first quarter. The expected seasonal increase in volume did not materialize due to continued inventory corrections in Europe and North America, decreased demand due to Europe’s slowing economies and economic uncertainty in North America. Consequently, during the second quarter in Europe and North America, we took approximately 120,000 tons of economic downtime, roughly double the first quarter level. We also conducted extensive annual maintenance outages, which we executed safely and efficiently.

With respect to paper demand, we believe that our customers have completed the majority of their inventory corrections. We are now seeing very early indications that global advertising may be starting to rebound and we would expect demand in Europe and North America to begin to improve.

In the second quarter, we returned $41 million of cash to shareowners through dividends and share repurchases for a total of $61 million in cash returns in the first half of 2023. Our board of directors declared a quarterly dividend of $0.25 per share for the third quarter, which we paid July 6. We remain committed to returning a total of $125 million in cash to shareowners this year.
more at: https://investors.sylvamo.com/news/news-details/2023/Sylvamo-Quarterly-Results-Meet-Guidance/default.aspx

Related Posts

Sappi accepts offer to sell three European graphic paper mills

Sappi Limited announced today that it has concluded an agreement with AURELIUS Investment Lux One S.à.r.l. regarding the divesture of its Maastricht Mill in the Netherlands, its Stockstadt Mill in Germany and its Kirkniemi Mill in Finland. Steve Binnie, CEO of Sappi Limited commented: “We are very happy to have reached agreement with AURELIUS to take ownership of the three mills. Although they no longer fit in Sappi’s portfolio, they are strong assets with good people." The mills included in the sale: Sappi Maastricht Mill produces 260,000 ton per annum (tpa) of coated woodfree paper and paperboard mainly sold to printers and packaging converters globally Sappi Stockstadt Mill is an integrated pulp and paper mill located in Germany, producing 145,000 tpa of pulp which is used to produce 220,000 tpa of coated and uncoated woodfree paper mainly sold into the European print market. Sappi Kirkniemi Mill is an integrated pulp and paper mill located in Finland, producing 300,000 tpa of bleached mechanical pulp which is used to produce approximately 750 000 tpa of a variety of coated mechanical paper grades used in the print publication industry globally.

UPM brings its first clinical product to market – FibDex® wound dressing

FibDex® wound dressing – made from nanofibrillar cellulose by UPM Biomedicals – has taken a significant step in its path to market, as leading medical device distributor Steripolar Oy now sells the product in Finland. FibDex is the first clinical product of renowned forest-based bioindustry company UPM and shows promising signs for future developments, such as cell therapy. ”We are excited to offer this Finnish product, made from Finnish raw material, first in the world to Finnish healthcare professionals and patients,” said Johana Kuncova-Kallio, Director of UPM Biomedicals. “Nanofibrillar cellulose has proven its potential both in the development of cell therapies and in clinical applications, and we are committed to further innovation.” Kaj Dahlström, CEO of Steripolar, added: “We were attracted to the ingenuity of FibDex. We are always looking for products and solutions that offer diverse and pain-free healing, while minimizing damage to the environment.”

Investigators look for the cause of fire a Wisconsin Rapids paper mill (wsaw.com)

Wisconsin Rapids fire officials say there’s an ongoing investigation into cause of a fire at the Verso Paper Mill on West Riverview Expressway. Multiple fire departments were called to help fight the fire Tuesday evening. It was mostly contained by 10:15pm. Witnesses say black smoke was seen rising from the part of the complex. A former employee of the mill says the fire was in the Kraft Mill where wood chips were cooked into pulp. The paper mill was opened in 1904. It was Rapids’ largest employer until it was shut down in the summer of 2020.
Back To Top
×Close search
Search